InsidersTradesSigma
Follow the 持田製薬株式会社 share price and the full insider trade history of the company, a listed issuer based in Japan. Shares trade on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €113.7bn. The latest transaction was reported on 10 April 2026 (Holding update). Among the most active insiders: Mochida Memorial Foundation for Medical and Pharmaceutical Research. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Mochida Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, and marketing of drugs. It focuses on therapeutic areas such as dermatology and neurology.